技术文章

Construction and Evaluation of Pancreatitis Animal Models: Acute Inflammation, Chronic Fibrosis, and Etiological Simulation Research

Pancreatitis animal models are used to simulate acute acinar cell injury, abnormal pancreatic enzyme activation, inflammatory cascade responses, microcirculatory disturbance, and chronic fibrotic progression. Model selection should be based on the research focus, such as acute pancreatitis (AP), severe necrotizing pancreatitis, chronic pancreatitis (CP), or a specific etiology. Cerulein, sodium taurocholate, L-arginine, pancreatic duct ligation, alcohol combined with a high-fat diet, and genetic background models correspond to different pathological entry points and cannot simply replace one another.

 

Keywords: pancreatitis model; animal modeling; acute pancreatitis; chronic pancreatitis; cerulein; sodium taurocholate; L-arginine; pancreatic enzyme activation; pancreatic fibrosis

 

1 Experimental Positioning of Pancreatitis Models

1.1 Core Objectives of Model Establishment

(1) Acute acinar cell injury

Acute pancreatitis models focus on acinar cell edema, vacuolization, premature pancreatic enzyme activation, inflammatory cell infiltration, and increased serum amylase and lipase levels. The cerulein model is suitable for studies of mild to moderate edematous AP. The sodium taurocholate retrograde pancreaticobiliary duct injection model is more suitable for biliary and necrotizing AP research. The L-arginine model is commonly used to evaluate more severe acinar cell injury, oxidative stress, and systemic inflammatory responses.

(2) Chronic inflammation and fibrotic progression

Chronic pancreatitis models focus more on acinar atrophy, ductal reaction, pancreatic stellate cell activation, collagen deposition, and decreased exocrine function. Repeated cerulein stimulation, pancreatic duct ligation, and alcohol combined with a high-fat diet can all be used for CP research, but their emphases differ. The repeated cerulein model emphasizes recurrent inflammatory injury, the pancreatic duct ligation model emphasizes duct obstruction and fibrosis, and the alcohol combined with high-fat diet model is closer to metabolism- and lifestyle-related etiologies.

(3) Etiological and molecular mechanism simulation

Different models correspond to different etiological clues. Biliary AP research can use the sodium taurocholate model; hereditary pancreatitis mechanisms can use PRSS1 mutation- or SPINK1 deficiency-related models; alcoholic CP research is better suited to alcohol exposure combined with a high-fat diet or repeated stimulation models. If the research focus is NF-κB, NLRP3, TGF-β/Smad, autophagy, or oxidative stress, the model should be selected according to the disease stage in which the pathway is involved, rather than only according to modeling convenience.

 

1.2 Experimental Animals and Model Selection

Mice and rats are the most commonly used animals in pancreatitis research. Mice are suitable for mechanistic studies, genetically modified models, and multi-index molecular detection. Rats are suitable for surgical manipulation, pancreaticobiliary duct injection, tissue sampling, and serum biochemical testing. When selecting a model, disease type, lesion severity, observation window, mortality risk, operational stability, and compatibility with evaluation indicators should all be considered.

 

Table 1 Selection Logic of Pancreatitis Animal Models

 

Research Purpose

Recommended Model

Main Mechanism

Applicable Evaluation Indicators

Mechanistic research on mild to moderate acute pancreatitis

Cerulein-induced model

CCK-like stimulation, acinar cell injury, inflammatory response

Amylase, lipase, pancreatic edema, MPO, TNF-α, IL-6

Biliary or necrotizing AP research

Sodium taurocholate retrograde pancreaticobiliary duct injection model

Bile acid toxicity, ductal hypertension, calcium overload, necrotizing inflammation

Histological necrosis score, IL-1β, NLRP3, MPO, mortality

Severe AP and systemic inflammation research

L-arginine-induced model

Acinar cell toxic injury, oxidative stress, inflammatory factor release

Amylase, lipase, MDA, SOD, LDH, remote organ injury indicators

Chronic inflammation and fibrosis research

Repeated cerulein stimulation model

Recurrent acinar injury, inflammation-repair cycle, fibrosis formation

α-SMA, Collagen I, TGF-β, Masson staining

Obstructive CP research

Pancreatic duct ligation model

Pancreatic juice retention, acinar atrophy, ductal reaction, and fibrosis

Acinar atrophy, duct dilation, collagen deposition, pancreatic weight

Alcoholic CP research

Alcohol combined with high-fat diet model

Alcohol metabolism, lipotoxicity, oxidative stress, and ER stress

ALDH, ALDH2, CHOP, MDA, inflammatory factors, fibrosis indicators

Hereditary pancreatitis research

PRSS1, SPINK1, and other genetic background models

Imbalanced trypsin activation, autophagy abnormalities, chronic inflammation

Trypsinogen, TAP, Cathepsin B, p62, STAT3

 

1.3 Common Inducing Factors and Modeling Positioning

Modeling reagents and inducing factors should be placed at the front end of model selection to explain the etiological background and applicable research directions simulated by different models. Evaluation products should be placed in the latter part of the article to explain how injury, inflammation, pancreatic enzyme activation, and histopathological changes are detected after model establishment.

 

Table 2 Common Inducing Factors and Modeling Positioning in Pancreatitis Animal Models

 

Modeling Category

Inducing Factor/Modeling Material

CAS No.

Main Simulated Type

Modeling Positioning

Chemically induced AP model

Cerulein/Ceruletide

17650-98-5

Mild to moderate acute pancreatitis

Induces acinar cell injury, abnormal pancreatic enzyme activation, and inflammatory responses through CCK-like stimulation; suitable for AP early mechanisms and drug protective effect research

Biliary AP model

Sodium Taurocholate

145-42-6

Biliary/necrotizing acute pancreatitis

Simulates bile reflux, ductal hypertension, and bile acid toxic injury through retrograde pancreaticobiliary duct injection; suitable for severe AP and necrotizing inflammation research

Severe AP model

L-Arginine

74-79-3

Severe acute pancreatitis

Induces acinar cell metabolic stress, oxidative stress, and inflammatory responses; suitable for pancreatic necrosis and remote organ injury research

Nutritional-metabolic AP model

Ethionine

67-21-0

Nutrition/metabolism-related acute pancreatitis

Often used together with a choline-deficient diet to simulate severe nutrition/metabolism disorder-related pancreatic injury

Alcoholic CP model

Ethanol

64-17-5

Alcoholic chronic pancreatitis

Used in alcohol exposure or alcohol combined with high-fat diet models; suitable for oxidative stress, lipotoxicity, and chronic inflammation research

Chronic inflammation-fibrosis model

Repeated cerulein stimulation

17650-98-5

Chronic pancreatitis/fibrosis

Induces acinar atrophy, stellate cell activation, and collagen deposition through recurrent acinar cell injury and inflammation-repair cycles

Obstructive CP model

Pancreatic duct ligation

-

Obstructive chronic pancreatitis

Simulates ductal hypertension, acinar atrophy, and fibrosis formation through impaired pancreatic juice drainage; suitable for ductal reaction and tissue remodeling research

Hereditary pancreatitis model

PRSS1 mutation model

-

Hereditary pancreatitis

Used to study abnormal trypsinogen activation, chronic inflammation, and genetic susceptibility

Genetic susceptibility model

SPINK1 deficiency/mutation model

-

Genetically susceptible pancreatitis

Used to study decreased trypsin inhibition capacity, autophagy abnormalities, and acinar cell injury

 

2 Chemically Induced Models of Acute Pancreatitis

2.1 Cerulein-Induced Model

(1) Model mechanism

Cerulein is a cholecystokinin analog that can overstimulate acinar cell secretory responses, causing abnormal zymogen granule trafficking, disrupted intracellular calcium signaling, and premature trypsinogen activation. This model usually shows pancreatic edema, acinar cell vacuolization, inflammatory cell infiltration, and increased serum amylase and lipase levels. It is suitable for studying early inflammatory amplification, acinar cell injury, and drug protective effects in AP.

(2) Experimental interpretation

The advantages of the cerulein model are good reproducibility, relatively stable operation, and low mortality. Its limitation is that the lesions are mostly edematous and mild to moderate, while necrosis and multi-organ injury are less prominent than in sodium taurocholate or L-arginine models. If used for drug screening, serum enzymology, pancreatic wet/dry weight ratio, HE score, MPO activity, and inflammatory factors should be evaluated together, rather than judging model severity only by increased amylase.

 

2.2 Sodium Taurocholate Retrograde Pancreaticobiliary Duct Injection Model

(1) Model mechanism

The sodium taurocholate model simulates bile reflux, pancreaticobiliary duct hypertension, and bile acid toxic injury through retrograde pancreaticobiliary duct injection. Bile acids can directly damage acinar cells and ductal epithelium, causing calcium overload, mitochondrial dysfunction, abnormal pancreatic enzyme activation, and tissue necrosis. This model is commonly used in biliary AP, severe AP, and necrotizing pancreatitis research.

(2) Experimental interpretation

This model produces severe lesions and can form marked edema, hemorrhage, necrosis, and systemic inflammatory responses, but it is highly sensitive to surgical technique, injection location, injection speed, and animal condition. Studies should focus on tissue necrosis extent, inflammatory infiltration, NLRP3 inflammasome, IL-1β, MPO activity, and remote organ injury. If the experimental goal is mild to moderate AP or early drug screening, this model may be too strong and should be used cautiously.

 

2.3 L-Arginine-Induced Model

(1) Model mechanism

High-load L-arginine can induce acinar cell metabolic stress, mitochondrial injury, and increased oxidative stress, thereby causing pancreatic parenchymal injury and inflammatory responses. This model is commonly used in studies of severe AP, pancreatic necrosis, systemic inflammatory response, and remote organ injury, and is especially suitable for observing the relationship between pancreatic injury and responses in the liver, lung, kidney, and other organs.

(2) Experimental interpretation

The lesion severity and animal tolerance of the L-arginine model are strongly affected by administration conditions, animal strain, body weight, and nutritional status. Evaluation should simultaneously detect pancreatic histology, serum enzymology, LDH, oxidative stress indicators, and multi-organ injury indicators. If the research focus is biliary etiology or ductal hypertension mechanisms, this model has insufficient etiological correspondence.

 

2.4 Choline-Deficient Ethionine-Supplemented Diet Model

The choline-deficient ethionine-supplemented diet model can induce severe acute pancreatic injury and systemic inflammatory responses and is commonly used in nutrition/metabolism disorder-related AP research. This model may show pancreatic necrosis, elevated inflammatory factors, and high mortality risk, but it is sensitive to animal sex, age, and feeding status. Because the model is relatively severe, ethical endpoints and observation windows should be clearly defined in the experimental design.

 

Table 3 Comparison of Acute Pancreatitis Models

 

Model Type

Common Inducing Factor

Main Pathological Features

Advantages

Limitations

Cerulein-induced model

Cerulein

Acinar cell edema, vacuolization, inflammatory infiltration

Good reproducibility; suitable for early mechanisms and drug screening

Mostly mild to moderate AP, with insufficient necrotic features

Sodium taurocholate model

Sodium taurocholate retrograde pancreaticobiliary duct injection

Hemorrhage, necrosis, severe inflammatory response

Close to biliary and necrotizing AP

Technically difficult, with relatively large within-group variation

L-arginine model

L-Arginine

Acinar necrosis, oxidative stress, systemic inflammation

Suitable for severe AP and remote organ injury research

Lesion severity is strongly affected by animal condition

Choline-deficient ethionine-supplemented diet model

Choline-deficient diet combined with ethionine

Severe pancreatitis and systemic inflammation

Suitable for nutrition/metabolism-related AP research

High mortality risk and strict condition control requirements

 

3 Chronic Pancreatitis Models

3.1 Repeated Cerulein Stimulation Model

(1) Model mechanism

Repeated cerulein stimulation causes acinar cells to repeatedly undergo injury, inflammatory infiltration, and repair. Long-term stimulation leads to acinar atrophy, ductal reaction, stellate cell activation, and collagen deposition. This model is commonly used to study early inflammation-to-fibrosis transition in CP and is also suitable for evaluating anti-inflammatory and anti-fibrotic candidate drugs.

(2) Experimental interpretation

The key to the repeated cerulein model is not the severity of a single acute injury, but the accumulation of fibrosis after repeated injury. Masson staining, Sirius Red staining, α-SMA, Collagen I/III, TGF-β, and Smad3 should serve as core evaluation indicators. If only amylase and lipase are detected, it is difficult to demonstrate whether CP modeling is sufficient.

 

3.2 Pancreatic Duct Ligation Model

(1) Model mechanism

Pancreatic duct ligation blocks pancreatic juice drainage, causing increased ductal pressure, acinar atrophy, inflammatory cell infiltration, and fibrosis formation. This model is suitable for simulating duct obstruction-related CP and pancreatic parenchymal structural remodeling, and is commonly used to study acinar-to-ductal metaplasia, stellate cell activation, and extracellular matrix deposition.

(2) Experimental interpretation

The evaluation focus of the pancreatic duct ligation model includes duct dilation, acinar atrophy, fibrosis extent, and changes in pancreatic tissue structure. This model requires high surgical consistency, and ligation site and postoperative observation time can significantly affect results. If used for drug intervention, the effects of drugs on inflammation, fibrosis, and tissue atrophy should be distinguished, rather than using pancreatic weight change as the only endpoint.

 

3.3 Alcohol Combined with High-Fat Diet Model

(1) Model mechanism

Alcohol exposure can increase ROS through acetaldehyde generation, CYP2E1 activation, and mitochondrial injury. A high-fat diet can enhance lipotoxicity, inflammatory responses, and endoplasmic reticulum stress. Their combination can promote acinar cell injury, stellate cell activation, and chronic fibrosis, making it more suitable for studying alcoholic or metabolism-related CP.

(2) Experimental interpretation

This model usually progresses slowly, and alcohol exposure alone may not reliably produce typical CP lesions. Experiments should focus on ALDH, ALDH2, CYP2E1, CHOP, GRP78, MDA, GSH, and fibrosis indicators. If the research goal is a clear fibrosis endpoint, it is often necessary to combine this model with repeated inflammatory stimulation or other injurious factors.

 

3.4 Genetic Background Models

PRSS1 mutation models can be used to simulate hereditary pancreatitis related to abnormal trypsinogen activation, while SPINK1 deficiency models can be used to study pancreatic enzyme imbalance caused by decreased trypsin inhibition capacity. Some models can also be combined with CFTR, CPA1, autophagy-related genes, or inflammatory pathway genes to study genetic susceptibility. The advantage of genetic background models is clear mechanism, while their limitation is a relatively single etiology and difficulty in fully covering human CP caused by the combined effects of alcohol, biliary factors, metabolism, genetics, and environmental factors.

 

Table 4 Comparison of Chronic Pancreatitis Models

 

Model Type

Modeling Characteristics

Main Mechanism

Applicable Research Direction

Key Control Points

Repeated cerulein model

Repeated stimulation induces inflammation-repair cycles

Acinar injury, persistent inflammation, fibrosis formation

Early CP mechanisms and anti-fibrotic efficacy

Stimulation cycle, observation endpoint, histological scoring

Pancreatic duct ligation model

Surgical blockage of pancreatic juice drainage

Ductal hypertension, acinar atrophy, fibrosis

Obstructive CP, ductal reaction, tissue remodeling

Ligation site, postoperative time, surgical consistency

Alcohol combined with high-fat diet model

Long-term metabolic and dietary intervention

Oxidative stress, lipotoxicity, ER stress

Alcoholic CP and metabolism-related pancreatic injury

Diet composition, exposure cycle, animal tolerance

PRSS1-related model

Expression of trypsinogen mutation

Abnormal pancreatic enzyme activation, chronic inflammation

Hereditary pancreatitis and inflammation-cancer transition

Genetic background, disease stage, phenotype stability

SPINK1-related model

Reduced trypsin inhibition capacity

Pancreatic enzyme imbalance, autophagy abnormalities, acinar injury

Genetic susceptibility, autophagy, and pancreatic enzyme regulation

Genotype confirmation and tissue injury severity

 

4 Mechanistic Evaluation of Pancreatitis Models

4.1 Pancreatic Enzyme Activation and Acinar Cell Injury

Premature trypsinogen activation is an important step in early AP injury. Cathepsin B can promote abnormal intracellular activation of trypsinogen, leading to acinar cell autodigestion, cell membrane injury, and initiation of inflammatory responses. Trypsin activity, TAP, trypsinogen, Cathepsin B, intracellular calcium signaling, and acinar cell vacuolization can serve as evaluation indicators for this step.

 

4.2 Inflammatory Cascade Response

After NF-κB pathway activation, the release of pro-inflammatory factors such as TNF-α, IL-1β, and IL-6 is promoted, further recruiting neutrophils and macrophages. In severe AP, the NLRP3 inflammasome, Caspase-1, and IL-1β maturation are closely associated with necrotizing inflammation and systemic inflammatory responses. MPO activity can be used to reflect the degree of neutrophil infiltration.

 

4.3 Oxidative Stress and Microcirculatory Disturbance

ROS accumulation, mitochondrial dysfunction, and reduced antioxidant capacity can aggravate acinar cell injury. Increased MDA and decreased SOD and GSH are commonly used to assess oxidative injury. In necrotizing AP, vascular endothelial injury, platelet activation, local ischemia, and microcirculatory disturbance should also be considered. When necessary, tissue perfusion, endothelial injury, and coagulation-related indicators should be detected together.

 

4.4 Chronic Fibrosis and Stellate Cell Activation

The core pathological changes of CP are acinar atrophy, ductal reaction, and fibrosis. After activation, pancreatic stellate cells express α-SMA and secrete Collagen I, Collagen III, and Fibronectin. The TGF-β/Smad3 pathway is an important regulatory axis in fibrosis formation. When evaluating CP models, histological staining and fibrosis-related molecular indicators should be used together to avoid judging chronic lesions only by inflammatory factors.

 

Table 5 Common Evaluation Indicators for Pancreatitis Models

 

Evaluation Level

Common Indicators

Application Value

Applicable Models

Serum enzymology

Amylase, lipase

Determines AP modeling success and acinar injury severity

Cerulein, sodium taurocholate, L-arginine

Gross injury

Pancreatic edema, hemorrhage, necrosis, wet/dry weight ratio

Determines lesion severity and tissue edema

AP models

Histology

HE score, necrotic area, inflammatory infiltration, acinar atrophy

Evaluates injury type and pathological stage

AP and CP models

Inflammatory response

TNF-α, IL-1β, IL-6, MPO

Determines inflammatory factor release and neutrophil infiltration

AP, severe AP, CP

Inflammasome

NLRP3, Caspase-1, IL-1β, GSDMD

Evaluates necrotizing inflammation and pyroptosis-related mechanisms

Sodium taurocholate and severe AP models

Oxidative stress

MDA, SOD, GSH, GSH-Px, ROS

Determines oxidative injury and antioxidant defense

AP and alcohol-related models

Pancreatic enzyme activation

Trypsin activity, TAP, trypsinogen, Cathepsin B

Analyzes abnormal pancreatic enzyme activation and acinar autodigestion

Cerulein and genetic background models

Cell injury

LDH, cell viability, cell death rate

Evaluates acinar cell injury and cytotoxicity in in vitro models

In vitro acinar cell models and AP models

Autophagy

LC3-II, Beclin-1, p62/SQSTM1

Evaluates autophagic flux and acinar cell stress

AP and SPINK1-related models

Fibrosis

α-SMA, Collagen I/III, Fibronectin, hydroxyproline

Determines stellate cell activation and ECM deposition

CP models

Fibrotic pathway

TGF-β, Smad2/3, p-Smad3

Analyzes fibrotic signaling pathways

Pancreatic duct ligation, repeated cerulein, alcohol models

Remote organ injury

Pulmonary edema, ALT, AST, Cr, BUN, inflammatory factors

Evaluates systemic injury in severe AP

Sodium taurocholate and L-arginine models

 

5 Supplementary Applications of In Vitro and Ex Vivo Models

5.1 Acinar Cell Injury Models

AR42J cells and primary pancreatic acinar cells can be used to simulate acinar cell stress, pancreatic enzyme activation, abnormal calcium signaling, oxidative stress, and inflammatory factor release. Cell models are suitable for preliminary mechanistic screening, such as NF-κB, NLRP3, autophagy, mitochondrial injury, and candidate drug protective effects.

Cell models cannot fully simulate pancreatic tissue structure, ductal pressure, immune cell infiltration, and microcirculatory disturbance. Therefore, in vitro results should be used as mechanistic clues, while key conclusions still need validation by animal models and histological results.

 

5.2 Pancreatic Stellate Cell Models

Pancreatic stellate cells are suitable for studying CP fibrosis mechanisms. TGF-β stimulation, alcohol metabolites, or inflammatory factors can induce stellate cell activation, characterized by increased α-SMA, increased collagen secretion, and enhanced extracellular matrix deposition. This model is suitable for preliminary screening of anti-fibrotic drugs, but cannot independently represent the complete CP disease course.

 

5.3 Pancreatic Tissue Slices and Organoid Models

Ex vivo pancreatic tissue slices can preserve partial tissue structure and cell-cell interactions, making them suitable for observing short-term effects of drugs on acinar cells, ductal reactions, and inflammatory signaling. Pancreatic organoids are more suitable for studying ductal epithelium, regeneration and repair, and genetic background-related mechanisms, but have limited ability to simulate inflammatory infiltration and blood flow factors.

 

Table 6 Application Positioning of In Vivo and In Vitro Models in Pancreatitis Research

 

Model Level

Common System

Applicable Question

Main Limitation

Animal models

Mice, rats, genetically engineered animals

Pancreatitis occurrence, inflammatory infiltration, fibrosis, drug efficacy evaluation

High cost, requiring ethical approval and model consistency control

Acinar cell models

AR42J, primary acinar cells

Pancreatic enzyme activation, calcium signaling, autophagy, oxidative stress

Lack tissue structure, immune microenvironment, and blood flow factors

Stellate cell models

Primary or passaged pancreatic stellate cells

Fibrosis, ECM deposition, TGF-β pathway

Cannot simulate acinar-ductal-immune cell interactions

Pancreatic tissue slices

Ex vivo pancreatic tissue

Local tissue response and short-term drug effects

Limited survival time and difficulty simulating long-term progression

Pancreatic organoids

Pancreatic ductal or acinar-related organoids

Epithelial repair, genetic mechanisms, drug screening

Insufficient simulation of inflammation and microcirculation

 

6 Related Product and Material Selection

 

Table 7 Products Related to Pancreatic Injury and Serum Enzymology Evaluation

 

Product Category

Cat. No.

Product/Material Name

Grade & Purity

Application Positioning

Amylase activity detection

G1501772

α-Amylase (α-AL) Activity Assay Kit (DNS, Micro Method)

BioReagent

Used for amylase activity detection in acute pancreatitis models; suitable for enzymatic evaluation of serum or tissue samples

Amylase activity detection

A1515869

α-Amylase (α-AMS) Activity Assay Kit (DNS, Colorimetric Method)

BioReagent

Used for α-amylase activity detection in AP models and can serve as one serum enzymology indicator

Amylase activity detection

A1515870

Amylase (AMS) Activity Assay Kit (Iodine Solution, Micro Method)

BioReagent

Used for total amylase activity detection; suitable for small-volume samples and multi-group comparisons

Amylase activity detection

A1515871

Amylase (AMS) Activity Assay Kit (Iodine Solution, Colorimetric Method)

BioReagent

Used for evaluating serum or tissue amylase activity in AP models

Animal sample amylase detection

EJ1515397

Rat Amylase (AMS) ELISA Kit

BioReagent

Used for detecting amylase levels in rat acute pancreatitis models

Animal sample pancreatic amylase detection

EJ1512270

Rat Amylase, Alpha 2A (PAMYα2) ELISA Kit

BioReagent

Used for detecting pancreas-derived amylase in rats; more suitable for pancreatic injury evaluation

Animal sample amylase detection

EJ1515460

Mouse Alpha Amylase(α-AMS) ELISA Kit

BioReagent

Used for detecting α-amylase levels in mouse AP models

Animal sample pancreatic amylase detection

EJ1513120

Mouse Amylase, Alpha 2A (PAMYα2) ELISA Kit

BioReagent

Used for detecting pancreas-derived amylase in mouse pancreatitis models

Lipase activity detection

L1515842

Lipase (LPS) Activity Assay Kit (Copper soap, Micro Method)

BioReagent

Used for lipase activity detection in AP models and can be combined with amylase to evaluate pancreatic exocrine enzyme release

Animal sample pancreatic lipase detection

EJ1515536

Mouse Lipase, Pancreatic (PL) ELISA Kit

BioReagent

Used for detecting pancreatic lipase levels in mouse pancreatitis models

Cell injury detection

L1501786

Lactate Dehydrogenase (LDH) Cytotoxicity Assay Kit (DNPH, Micro Method)

BioReagent

Used for detecting cell injury and necrosis degree; suitable for in vitro mechanistic validation

LDH activity detection

L1510342

Lactate Dehydrogenase (LDH) Activity Assay Kit (LD-L, Colorimetric Method)

BioReagent

Used for LDH activity evaluation in tissue or cell samples, reflecting the degree of cell injury

LDH activity detection

L1521751

Lactate Dehydrogenase (LDH) Activity Assay Kit (LD-P, UV Colorimetric Method)

BioReagent

Used for LDH activity detection and can serve as a supplementary indicator of pancreatic cell injury

Cell injury detection

L1521750

Lactate Dehydrogenase (LDH) Cytotoxicity Assay Kit (DNPH, Colorimetric Method)

BioReagent

Used for cytotoxicity detection in in vitro pancreatic cell injury models

Animal sample LDH detection

EJ1511965

Rat Lactate Dehydrogenase (LDH) ELISA Kit

BioReagent

Used for evaluating tissue injury or systemic injury in rat AP models

Animal sample LDH detection

EJ1512628

Mouse Lactate Dehydrogenase (LDH) ELISA Kit

BioReagent

Used for detecting LDH levels in mouse pancreatitis models

Animal sample LDH-A detection

EJ1511966

Rat Lactate Dehydrogenase A (LDHA) ELISA Kit

BioReagent

Can be used for analysis related to cell injury and metabolic stress in rat models

Animal sample LDH-A detection

EJ1512629

Mouse Lactate Dehydrogenase A (LDH-A) ELISA Kit

BioReagent

Can be used for evaluating tissue injury and glycolytic stress in mouse pancreatitis models

 

Table 8 Products Related to Trypsin Activation and Cathepsin B Mechanism Evaluation

 

Product Category

Cat. No.

Product/Material Name

Grade & Purity

Application Positioning

Trypsin activity detection

T1515849

Trypsase Activity Assay Kit (TAME, Micro Method)

BioReagent

Used for evaluating trypsin activity; suitable for studying abnormal pancreatic enzyme activation in AP models

Trypsin activity detection

T1515968

Trypsin Activity Assay Kit (TAME, Colorimetric Method)

BioReagent

Used for trypsin activity detection and can serve as an indicator of pancreatic autodigestion mechanisms

Trypsin detection

EJ1514725

Human Trypsin ELISA Kit

BioReagent, for ELISA

Suitable for trypsin-related detection in human samples or human-derived in vitro models

TAP detection

EJ1515426

Rat Trypsinogen Activation Peptide (TAP) ELISA Kit

BioReagent

Used for evaluating the degree of trypsinogen activation in rat AP models; suitable for early pancreatic enzyme activation research

TAP detection

EJ1515537

Mouse Trypsinogen Activation Peptide (TAP) ELISA Kit

BioReagent

Used for TAP detection in mouse AP models, reflecting abnormal trypsinogen activation

Cathepsin B mechanism detection

Ab093155

Cathepsin B Mouse mAb

Carrier-free, ExactAb™, azide-free, validated, high performance, see COA

Used for Cathepsin B expression detection; suitable for research on abnormal trypsinogen activation mechanisms

Cathepsin B mechanism detection

Ab325784

Recombinant Cathepsin B Antibody

KD Validation

Used for Cathepsin B-related mechanistic validation and can be combined with WB, IHC, or IF experimental design

Cathepsin B protein

rp183609

Recombinant Human Cathepsin B Protein

Animal-free, carrier-free, bioactive, ActiBioPure™, His tag, PBS Only, ≥95%(SDS-PAGE)

Can be used for Cathepsin B-related in vitro enzymology, antibody validation, or mechanism research

Cathepsin B protein

rp153668

Recombinant Mouse Cathepsin B Protein

Animal-free, carrier-free, bioactive, ActiBioPure™, His tag, ≥95%(SDS-PAGE)

Can be used for mouse-derived mechanism research, methodological validation, or positive material setup

 

Table 9 Supplementary Evaluation Products for Alcohol-Related Chronic Pancreatic Injury

 

Product Category

Cat. No.

Product/Material Name

Grade & Purity

Application Positioning

Acetaldehyde metabolism detection

A1515995

Acetaldehyde Dehydrogenase (ALDH) Activity Assay Kit (WST-8, Micro Method)

BioReagent

Used for evaluating acetaldehyde metabolism capacity in alcoholic chronic pancreatic injury models

Acetaldehyde metabolism detection

A1515994

Acetaldehyde Dehydrogenase (ALDH) Activity Assay Kit (WST-8, Colorimetric Method)

BioReagent

Used for ALDH activity detection in alcohol exposure-related models

Acetaldehyde metabolism detection

A1515803

Acetaldehyde Dehydrogenase (ALDH) Activity Assay Kit (UV Micro Method)

BioReagent

Used for research linking alcohol metabolism and oxidative stress

Animal sample ALDH2 detection

EJ1511964

Rat Aldehyde Dehydrogenase, Mitochondrial (ALDH2) ELISA Kit

BioReagent

Used for detecting ALDH2 levels in rat alcoholic CP models

Animal sample ALDH detection

EJ1512625

Mouse Acetaldehyde Dehydrogenase (ALDH) ELISA Kit

BioReagent

Used for evaluating ALDH levels in mouse alcohol exposure models

Animal sample ALDH2 detection

EJ1512626

Mouse Aldehyde Dehydrogenase, Mitochondrial (ALDH2) ELISA Kit

BioReagent

Used for ALDH2-related detection in mouse alcoholic pancreatic injury models

 

Table 10 Products Related to Pancreatic Histopathological Evaluation

 

Product Category

Cat. No.

Product/Material Name

Grade & Purity

Application Positioning

Histological staining

H1506002

Modified Hematoxylin-Eosin (HE) Staining Kit

BioReagent, for microscopy, for cell culture

Used for basic pathological evaluation of pancreatic necrosis, edema, inflammatory infiltration, and acinar structural destruction

Histological staining

H1508526

Hematoxylin-Eosin (HE) High-Definition Consistent Staining Kit (High-Definition Stable Staining)

BioReagent, biological stain, for microscopy

Used for pancreatic tissue HE staining; suitable for pathological scoring and image presentation

Histological staining

H1508460

Hematoxylin-Eosin (HE) Staining Kit (with Differentiating Solution)

BioReagent, biological stain, for microscopy

Used for routine HE staining of pancreatic tissue in AP/CP models

Histological staining

H1508459

Hematoxylin-Eosin (HE) Staining Kit (with Differentiating Solution and Bluing Solution)

BioReagent, biological stain, for microscopy

Used for routine pathological observation of pancreatic tissue; suitable for determining model success and injury scoring

 

7 Common Questions

7.1 How Should the Cerulein Model and Sodium Taurocholate Model Be Selected in Acute Pancreatitis Research?

The cerulein model is suitable for mild to moderate AP, acinar cell injury, and early inflammatory mechanism research. It has relatively good model stability and is suitable for preliminary drug screening. The sodium taurocholate model is more suitable for biliary AP, necrotizing AP, and severe inflammatory response research, but has higher operational difficulty and mortality risk. If the research goal is inflammatory pathways or preliminary screening of protective effects, the cerulein model is more appropriate. If the research focuses on necrosis, microcirculatory disturbance, or severe AP, the sodium taurocholate model should be selected.

 

7.2 Can Chronic Pancreatitis Models Be Evaluated Only by Serum Amylase and Lipase?

This is not recommended. Serum amylase and lipase mainly reflect acute acinar injury and have limited explanatory power for CP fibrosis, acinar atrophy, and decreased exocrine function. CP models should focus on histological staining, α-SMA, Collagen I/III, TGF-β/Smad, hydroxyproline, and ductal reaction indicators.

 

7.3 Why Does the Alcohol Combined with High-Fat Diet Model Often Need Additional Stimulation?

Alcohol exposure or a high-fat diet alone may sometimes induce only metabolic stress and mild inflammation, and may not reliably form typical CP fibrosis. Combining repeated inflammatory stimulation or other injurious factors can enhance acinar cell injury, stellate cell activation, and collagen deposition, making it more suitable for studying chronic progression of alcoholic or metabolism-related CP.

 

7.4 How Should Inflammatory Indicators and Histological Results Be Interpreted Together in Pancreatitis Models?

Elevated inflammatory factors indicate that inflammatory responses are activated, but they cannot independently prove the extent of pancreatic tissue injury. In AP models, TNF-α, IL-1β, IL-6, and MPO should be interpreted together with HE score, necrosis extent, and serum enzymology. In CP models, fibrosis staining and ECM indicators should be further combined to determine the degree of chronic remodeling.

 

7.5 What Is the Significance of TAP Detection in AP Models?

TAP, or trypsinogen activation peptide, reflects the degree of abnormal trypsinogen activation. Compared with serum amylase detection alone, TAP is closer to pancreatic enzyme activation and acinar autodigestion mechanisms, and is suitable for early mechanistic evaluation in AP models such as cerulein, sodium taurocholate, and L-arginine models.

 

Pancreatitis animal models should be selected according to AP, severe AP, CP fibrosis, or specific etiologies. Chemical models are suitable for acute injury and inflammatory mechanism research. Surgical and dietary models are suitable for chronic progression and fibrosis research. Genetic background models are used to analyze genetic susceptibility and key molecular pathways.

 

For more related articles, please see below:

[1] The Technology Driving Biomedical Revolution — Animal Modeling

[2] Animal Modeling—Tumor Disease Models

[3] A Detailed Guide to the Construction of Animal Models for Metabolic Diseases

[4] Methods for Establishing Animal Models of Cardiovascular Diseases

[5] Methods for Establishing Models of Nervous System Diseases

[6] Establishment of Common Animal Disease Models and Their Experimental Methods

目录: 技术文章

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Construction and Evaluation of Pancreatitis Animal Models: Acute Inflammation, Chronic Fibrosis, and Etiological Simulation Research》. 阿拉丁知识库,更新于 2026年8月6日。 https://www.aladdin-e.com/zh_cn/faqs/acute-inflammation-chronic-fibrosis-and-etiological-simulation-research-en.html